logo
Please note!
This fact brief was originally published as an experiment to test the concepts behind fact briefs.
Readers should be aware that while there is still a lot of useful information in fact briefs like this one, not all of them reflect Gigafact's current methods and standards for fact briefs. If you come across any that you feel are out of date, don't hesitate to contact us at support@gigafact.org.

Did Pfizer's CEO say the company's COVID-19 pill will contain a microchip that transmits information?

By Christiana Dillard
NO

An online article making the claim uses a clip of Pfizer CEO Albert Bourla speaking in 2018 — well before the start of the COVID-19 pandemic.

A Pfizer spokesperson told Lead Stories that the claim is false.

Speaking at a forum at the 2018 World Economic Forum, Bourla was discussing ingestible technology unrelated to the yet-undeveloped Paxlovid, Pfizer's COVID-19 treatment pill. Ingestible technology, also known as a "smart pill," allows patients and health care providers to track health conditions. 

Bourla talked about a "smart pill" approved by the FDA in 2017 that can track when the patient took the drug. Bourla brought up the drug to acknowledge advances in the relationship between technology and patient engagement.

The emergency use authorization issued by the FDA for Pfizer's Paxlovid does not mention a microchip.

This fact brief is responsive to conversations such as this one.
ABOUT THE CONTRIBUTOR
Lead Stories is a fact checking and debunking website at the intersection of big data and journalism that launched in 2015. It scouts for trending stories, images, videos and posts that contain false information in order to fact check them as quickly as possible. It actively monitors the fake-news ecosystem and doesn’t wait for reader tips or reports before getting started on a story.
FACT BRIEF BY
facebook
twitter
email
email